Login

VASO ACTIVE PHARMACEUTICALS INC 4 SEC Filings

Filed On Filing
28 Dec 2004 Form 4: Anderson Robert Edward, Director

Granted 30,000 Non-Employee Director Stock Options

28 Dec 2004 Form 4: Adams William P, Director

Granted 30,000 Non-Employee Director Stock Options

28 Dec 2004 Form 4: Hurd Dorothy Anne, Director

Granted 30,000 Non-Employee Director Stock Options

28 Dec 2004 Form 4: Guerriero Ralph Ronald, Director

Granted 30,000 Non-Employee Director Stock Options

23 Dec 2004 Form 4: Strasnick Brian, Director

Granted 30,000 Non-Employee Director Stock Options

22 Dec 2004 Form 4: Fromm Gary, Director

Granted 30,000 Non-Employee Director Stock Options

22 Dec 2004 Form 4: Shear Bruce A, Director

Granted 30,000 Non-Employee Director Stock Options

21 Dec 2004 Form 4: Toh Henry Y L, Director

Granted 30,000 Non-Employee Director Stock Options

21 Dec 2004 Form 4: Morrell Steven, Director

Granted 30,000 Non-Employee Director Stock Options

25 Feb 2004 Form 4: Masiz John J, Director

Acquired 3,000,000 shares (Other Transaction)

24 Feb 2004 Form 4: Anderson Robert Edward, Director

Bought 1,000 shares ($28.5K) · Bought 1,000 shares ($26.3K)

13 Feb 2004 Form 4: Masiz John J, Director

Granted 100,000 Employee Stock Option (Right to Buy)

13 Feb 2004 Form 4: Frattaroli Joseph, Director

Granted 30,000 Employee Stock Option (Right to Buy)

13 Feb 2004 Form 4: Carter Stephen G, Director

Granted 75,000 Employee Stock Option (Right to Buy)

13 Feb 2004 Form 4: Seifert Kevin J, Director

Granted 75,000 Employee Stock Option (Right to Buy)

22 Jan 2004 Form 4: Anderson Robert Edward, Director

Bought 2,000 shares ($13.2K) · Bought 8,000 shares ($57.3K)

18 Dec 2003 Form 4: Strasnick Brian, Director

Received 21,411 shares by conversion ($1.15B)

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support